Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Cottu

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Breast (Edinburgh, Scotland)|September 28, 2014
Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancerVictor Pernin, Lisa Belin, Paul Cottu, et al.
NPJ Breast Cancer|February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancerClara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.
BMC Health Services Research|November 2, 2013
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational studySandrine Baffert, Paul Cottu, Youlia M Kirova, et al.
Breast (Edinburgh, Scotland)|March 12, 2021
Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancerPietro Lapidari, Arnauld Gbenou, Julie Havas, et al.
Cancer|January 16, 2023
Baseline quality of life and chemotherapy toxicities in patients with early breast cancerIdlir Licaj, Elodie Coquan, Tienhan Sandrine Dabakuyo-Yonli, et al.
Breast Cancer Research and Treatment|September 24, 2021
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatiguePietro Lapidari, Nardjes Djehal, Julie Havas, et al.
Breast Cancer Research : BCR|January 18, 2012
Molecular profiling of patient-derived breast cancer xenograftsFabien Reyal, Charlotte Guyader, Charles Decraene, et al.
Breast Cancer Research : BCR|November 16, 2019
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trialWilliam Jacot, Paul Cottu, Frederique Berger, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2016
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trialRoman Rouzier, Sébastien Gouy, Frédéric Selle, et al.
International Journal of Cancer|April 30, 2022
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancerSofiane Allali, Matthieu Carton, Thomas Sarrade, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Breast (Edinburgh, Scotland)|September 28, 2014
Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancerVictor Pernin, Lisa Belin, Paul Cottu, et al.
NPJ Breast Cancer|February 13, 2025
Clinico-pathological factors predicting pathological response in early triple-negative breast cancerClara Helal, Lounes Djerroudi, Toulsie Ramtohul, et al.
BMC Health Services Research|November 2, 2013
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational studySandrine Baffert, Paul Cottu, Youlia M Kirova, et al.
Breast (Edinburgh, Scotland)|March 12, 2021
Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancerPietro Lapidari, Arnauld Gbenou, Julie Havas, et al.
Cancer|January 16, 2023
Baseline quality of life and chemotherapy toxicities in patients with early breast cancerIdlir Licaj, Elodie Coquan, Tienhan Sandrine Dabakuyo-Yonli, et al.
Breast Cancer Research and Treatment|September 24, 2021
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatiguePietro Lapidari, Nardjes Djehal, Julie Havas, et al.
Breast Cancer Research : BCR|January 18, 2012
Molecular profiling of patient-derived breast cancer xenograftsFabien Reyal, Charlotte Guyader, Charles Decraene, et al.
Breast Cancer Research : BCR|November 16, 2019
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trialWilliam Jacot, Paul Cottu, Frederique Berger, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2016
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trialRoman Rouzier, Sébastien Gouy, Frédéric Selle, et al.
International Journal of Cancer|April 30, 2022
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancerSofiane Allali, Matthieu Carton, Thomas Sarrade, et al.
Pageof 14